BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Personalized medicine
,
Lipitor
,
rs2476601
,
PPARA
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human somatostatin receptor 5
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohi…
Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergi…
Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas.
Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation…
Characterization of intracellular signaling mediated by human somatostatin receptor 5: role of the D…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial …
Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms
Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ